185 related articles for article (PubMed ID: 26275671)
1. ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.
Li D; Pise MN; Overman MJ; Liu C; Tang H; Vadhan-Raj S; Abbruzzese JL
Cancer Med; 2015 Nov; 4(11):1651-8. PubMed ID: 26275671
[TBL] [Abstract][Full Text] [Related]
2. Use of thrombin-based hemostatic matrix during meningioma resection: a potential risk factor for perioperative thromboembolic events.
Safaee M; Sun MZ; Oh T; Aghi MK; Berger MS; McDermott MW; Parsa AT; Bloch O
Clin Neurol Neurosurg; 2014 Apr; 119():116-20. PubMed ID: 24635939
[TBL] [Abstract][Full Text] [Related]
3. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cetin MS; Ozcan Cetin EH; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study.
Ben Q; Wang K; Yuan Y; Li Z
Int J Cancer; 2011 Mar; 128(5):1179-86. PubMed ID: 20473916
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer.
Menapace LA; Peterson DR; Berry A; Sousou T; Khorana AA
Thromb Haemost; 2011 Aug; 106(2):371-8. PubMed ID: 21713322
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
Wang DS; Chen DL; Ren C; Wang ZQ; Qiu MZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
Int J Cancer; 2012 Jul; 131(2):461-8. PubMed ID: 21858814
[TBL] [Abstract][Full Text] [Related]
7. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
[TBL] [Abstract][Full Text] [Related]
8. ABO blood group and the risk of pancreatic cancer.
Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
[TBL] [Abstract][Full Text] [Related]
9. Deep vein thrombosis and/or pulmonary embolism concurrent with superficial vein thrombosis of the legs: cross-sectional single center study of prevalence and risk factors.
Hirmerova J; Seidlerova J; Subrt I
Int Angiol; 2013 Aug; 32(4):410-6. PubMed ID: 23822944
[TBL] [Abstract][Full Text] [Related]
10. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics.
Sallah S; Wan JY; Nguyen NP
Thromb Haemost; 2002 Apr; 87(4):575-9. PubMed ID: 12008937
[TBL] [Abstract][Full Text] [Related]
11. Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer.
Epstein AS; Soff GA; Capanu M; Crosbie C; Shah MA; Kelsen DP; Denton B; Gardos S; O'Reilly EM
Cancer; 2012 Jun; 118(12):3053-61. PubMed ID: 21989534
[TBL] [Abstract][Full Text] [Related]
12. Patient-based and surgical characteristics associated with the acute development of deep venous thrombosis and pulmonary embolism after spine surgery.
Schoenfeld AJ; Herzog JP; Dunn JC; Bader JO; Belmont PJ
Spine (Phila Pa 1976); 2013 Oct; 38(21):1892-8. PubMed ID: 23778367
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of pulmonary embolism associated with upper-extremity deep venous thrombosis.
Levy MM; Albuquerque F; Pfeifer JD
Ann Vasc Surg; 2012 Oct; 26(7):964-72. PubMed ID: 22749742
[TBL] [Abstract][Full Text] [Related]
14. Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer.
Dandona M; Linehan D; Hawkins W; Strasberg S; Gao F; Wang-Gillam A
Pancreas; 2011 Aug; 40(6):931-7. PubMed ID: 21747317
[TBL] [Abstract][Full Text] [Related]
15. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.
Egawa N; Lin Y; Tabata T; Kuruma S; Hara S; Kubota K; Kamisawa T
World J Gastroenterol; 2013 Apr; 19(16):2537-42. PubMed ID: 23674856
[TBL] [Abstract][Full Text] [Related]
16. ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer.
Tanaka Y; Kumagi T; Terao T; Kuroda T; Yokota T; Azemoto N; Imamura Y; Uesugi K; Kisaka Y; Shibata N; Koizumi M; Ohno Y; Kanemitsu K; Yukimoto A; Tange K; Nishiyama M; Miyake T; Miyata H; Ishii H; Abe M; Hiasa Y;
Intern Med; 2020; 59(6):761-768. PubMed ID: 32173688
[TBL] [Abstract][Full Text] [Related]
17. B blood group: A strong risk factor for venous thromboembolism recurrence.
Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolisms in Advanced Pancreatic Cancer: A Retrospective Analysis of 475 Patients.
Ishigaki K; Nakai Y; Isayama H; Saito K; Hamada T; Takahara N; Mizuno S; Mohri D; Kogure H; Matsubara S; Yamamoto N; Tada M; Koike K
Pancreas; 2017 Sep; 46(8):1069-1075. PubMed ID: 28787333
[TBL] [Abstract][Full Text] [Related]
19. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study.
Chung WS; Lin CL; Kao CH
Thromb Haemost; 2015 Oct; 114(4):812-8. PubMed ID: 26271946
[TBL] [Abstract][Full Text] [Related]
20. Risks and impacts of thromboembolism in patients with pancreatic cancer.
Chan LL; Lam KY; Lam DCM; Lau YM; Li L; Ng KKC; Tang RSY; Chan SL
Hong Kong Med J; 2023 Oct; 29(5):396-403. PubMed ID: 37789507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
